New TeaCrine Clinical Trial Illustrates Increased Potency When Combined with Caffeine

Compound Solutions, Inc., exclusive global distributor of patent-protected TeaCrine®, today announced several groundbreaking findings from a new human clinical trial.
TAGS: Archive
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.